Stephen Baxter
Stock Analyst at Wells Fargo
(3.15)
# 1,083
Out of 5,157 analysts
257
Total ratings
46.63%
Success rate
0.51%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CON Concentra Group Holdings Parent | Maintains: Overweight | $25 → $28 | $22.44 | +24.78% | 1 | Mar 5, 2026 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $235 → $212 | $186.53 | +13.65% | 18 | Mar 2, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $43 → $50 | $41.34 | +20.95% | 9 | Mar 2, 2026 | |
| AGL agilon health | Maintains: Overweight | $1 → $1.5 | $0.58 | +157.95% | 11 | Feb 27, 2026 | |
| MDLN Medline | Maintains: Equal-Weight | $42 → $47 | $42.88 | +9.61% | 2 | Feb 27, 2026 | |
| MOH Molina Healthcare | Downgrades: Equal-Weight | $208 → $141 | $141.32 | -0.23% | 23 | Feb 20, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $290 → $206 | $173.62 | +18.65% | 14 | Feb 18, 2026 | |
| CNC Centene | Maintains: Equal-Weight | $43 → $44 | $36.40 | +20.88% | 26 | Feb 18, 2026 | |
| COR Cencora | Maintains: Overweight | $405 → $429 | $352.19 | +21.81% | 6 | Feb 10, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $237 → $256 | $217.04 | +17.95% | 11 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $914 → $925 | $928.69 | -0.40% | 10 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $370 | $282.34 | +31.05% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $424 → $391 | $282.68 | +38.32% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $452 → $481 | $537.64 | -10.53% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $38 | $34.05 | +11.60% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $252 → $229 | $237.42 | -3.55% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3 → $2 | $3.38 | -40.83% | 12 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $14 → $11 | $13.30 | -17.29% | 13 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $102 | $76.32 | +33.65% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $262.44 | +14.31% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $5.57 | +169.30% | 3 | Apr 29, 2024 |
Concentra Group Holdings Parent
Mar 5, 2026
Maintains: Overweight
Price Target: $25 → $28
Current: $22.44
Upside: +24.78%
Universal Health Services
Mar 2, 2026
Maintains: Equal-Weight
Price Target: $235 → $212
Current: $186.53
Upside: +13.65%
BrightSpring Health Services
Mar 2, 2026
Maintains: Overweight
Price Target: $43 → $50
Current: $41.34
Upside: +20.95%
agilon health
Feb 27, 2026
Maintains: Overweight
Price Target: $1 → $1.5
Current: $0.58
Upside: +157.95%
Medline
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $42 → $47
Current: $42.88
Upside: +9.61%
Molina Healthcare
Feb 20, 2026
Downgrades: Equal-Weight
Price Target: $208 → $141
Current: $141.32
Upside: -0.23%
Humana
Feb 18, 2026
Maintains: Equal-Weight
Price Target: $290 → $206
Current: $173.62
Upside: +18.65%
Centene
Feb 18, 2026
Maintains: Equal-Weight
Price Target: $43 → $44
Current: $36.40
Upside: +20.88%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $405 → $429
Current: $352.19
Upside: +21.81%
Cardinal Health
Feb 10, 2026
Maintains: Overweight
Price Target: $237 → $256
Current: $217.04
Upside: +17.95%
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $914 → $925
Current: $928.69
Upside: -0.40%
Jan 30, 2026
Maintains: Overweight
Price Target: $400 → $370
Current: $282.34
Upside: +31.05%
Jan 30, 2026
Maintains: Overweight
Price Target: $424 → $391
Current: $282.68
Upside: +38.32%
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $452 → $481
Current: $537.64
Upside: -10.53%
Jan 7, 2026
Maintains: Overweight
Price Target: $31 → $38
Current: $34.05
Upside: +11.60%
Jan 7, 2026
Maintains: Overweight
Price Target: $252 → $229
Current: $237.42
Upside: -3.55%
Jan 7, 2026
Maintains: Underweight
Price Target: $3 → $2
Current: $3.38
Upside: -40.83%
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $13.30
Upside: -17.29%
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $76.32
Upside: +33.65%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $262.44
Upside: +14.31%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $5.57
Upside: +169.30%